Heavy Menstrual Bleeding Progestin Treatment in Bleeding Disorders Study

Recruiting

LNG-IUD vs. NETAHeavy Menstrual Bleeding Progestin Treatment in Bleeding Disorders Study

Sponsor:

Oregon Health and Science University

Code:

NCT05916469

Conditions

Heavy Menstrual Bleeding

Bleeding Disorder

Von Willebrand Diseases

Eligibility Criteria

Sex: Female

Age: 10 - 24

Healthy Volunteers: Not accepted

Interventions

Levonorgestrel Intrauterine System

Norethindrone Acetate

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-05-25. This information was provided to ClinicalTrials.gov by Oregon Health and Science University on 2025-12-17.